Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.

Jun 27

Written By Jonathan Karush

Wall Street Journal

Jonathan Karush

Patients Not PBMs Coalition Calls on Lawmakers to Create Oversight of Pharmacy Benefit Managers

3Axis Report Scrutinizes PBM Spread Pricing Practice